Flavia Pease is recorded as Board Member at Insulet Corp (PODD) since January 1, 2024 and CFO at Insulet Corp (PODD). The newest filing on record that lists Flavia Pease as CFO at Insulet Corp (PODD) is dated April 6, 2026. Earlier roles on record: CFO at Charles River Laboratories International, Inc. (CRL) until September 29, 2025. Insulet Corp reported in an 8-K filed January 18, 2024 that Flavia Pease was appointed Class II director, effective January 18, 2024. The proxy statement of Insulet Corp reports total compensation of $5,160,761 for Flavia Pease in fiscal 2025, including a base salary of $148,500. Disclosed compensation is on record for 4 fiscal years. Flavia Pease has spoken on 15 earnings calls and 2 other investor events across 2 companies, most recently for Insulet Corp on September 9, 2026. Those appearances were for Charles River Laboratories International, Inc. (CRL) and Insulet Corp (PODD). Insulet Corp is classified in the Medical Devices industry within the Healthcare sector. Other companies whose calls Flavia Pease spoke on are classified in the Healthcare sector. Other leadership on record at Insulet Corp includes Ashley A. McEvoy (CEO and Board Member), Ashley McEvoy (CEO and Board Member), Timothy J. Scannell (Chairman) and 7 others.
“On January 18, 2024, the Board of Directors (the "Board") of Insulet Corporation (the "Company") appointed Flavia Pease and Tim Stonesifer as Class II and Class I directors, respectively, effective January 18, 2024.”
Insulet Corp Form 8-K, filed January 18, 2024
· Read the filing
Flavia Pease on recent calls
“I think what I would say is, you know, the 10% on type 1 is what we've talked about before. And as we said, type 2, we had already assumed that it would be higher than that.”
“The Insulet team delivered another strong quarter with $802 million in total revenue, an increase of 23.5% on a reported basis and 22.7% on a constant currency basis.”
“Yeah, to your point, deductibles reset every year, and there's normal seasonality in the category. We saw that in 2023 and in 2024. Last year was a little masked.”
“As Ashley highlighted, the Insulet team delivered a strong start to the year. First quarter total revenues of $762 million increased 34% on a reported basis and 30% on a constant currency basis.”
